| |
| |
|
| Insider
Information: |
Patou Gary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
37,714 |
|
|
Indirect Shares
|
5,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$20,842 |
|
|
| Total
Shares |
43,318 |
|
|
| Total
Value |
$20,842 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
14,141 |
2004-11-02 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2014-08-07 |
0 |
2014-08-07 |
702 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
– • – |
2006-01-09 |
4 |
AS |
$2.45 |
$77,158 |
D/D |
(30,919) |
325,926 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
– • – |
2006-01-12 |
4 |
AS |
$2.50 |
$25,000 |
D/D |
(10,000) |
315,926 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
officerTitle |
– • – |
2006-01-27 |
4 |
AS |
$2.15 |
$21,500 |
D/D |
(10,000) |
305,926 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2004-12-03 |
4/A |
AS |
$3.57 |
$265,965 |
D/D |
(74,500) |
69,951 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-28 |
4 |
OE |
$0.07 |
$661 |
D/D |
9,445 |
361,348 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-28 |
4 |
AS |
$2.15 |
$18,275 |
D/D |
(8,500) |
352,848 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-29 |
4 |
OE |
$0.07 |
$1,283 |
D/D |
18,334 |
371,182 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-29 |
4 |
AS |
$2.21 |
$36,465 |
D/D |
(16,500) |
354,682 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-30 |
4 |
OE |
$0.07 |
$389 |
D/D |
5,556 |
360,238 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-30 |
4 |
AS |
$2.25 |
$11,250 |
D/D |
(5,000) |
355,238 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-31 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
377,460 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-03-31 |
4 |
AS |
$2.27 |
$45,400 |
D/D |
(20,000) |
357,460 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-04-26 |
4 |
AS |
$2.05 |
$1,025 |
D/D |
(500) |
363,410 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-16 |
4 |
AS |
$1.90 |
$66,500 |
D/D |
(35,000) |
367,299 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-16 |
4 |
OE |
$1.18 |
$45,889 |
D/D |
38,889 |
402,299 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-20 |
4 |
OE |
$1.18 |
$6,556 |
D/D |
5,556 |
372,855 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-20 |
4 |
AS |
$2.11 |
$10,550 |
D/D |
(5,000) |
367,855 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-21 |
4 |
OE |
$0.07 |
$11,475 |
D/D |
16,667 |
384,522 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-21 |
4 |
AS |
$2.34 |
$35,100 |
D/D |
(15,000) |
369,522 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-22 |
4 |
OE |
$0.07 |
$1,944 |
D/D |
27,778 |
397,300 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-06-22 |
4 |
AS |
$2.58 |
$64,500 |
D/D |
(25,000) |
372,300 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-08 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
394,522 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-08 |
4 |
AS |
$2.63 |
$52,600 |
D/D |
(20,000) |
374,522 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-14 |
4 |
OE |
$0.07 |
$389 |
D/D |
5,556 |
380,078 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2005-07-14 |
4 |
AS |
$2.60 |
$13,000 |
D/D |
(5,000) |
375,078 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
